Skip to content

Evaluation of World Health Organisation (WHO) cardiovascular disease (CVD)-risk management package - scenario one (Sri Lanka)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN48141450
Enrollment
Unknown
Registered
2005-06-07
Start date
2004-05-07
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System Hypertension

Interventions

20 primary health care facilities. 10 facilities to apply the study protocol based on Scenario One of the WHO CVD-Risk Management Package (intervention sites). Other 10 to continue with conventional t

Sponsors

The Department of Cardiovascular Diseases (CVD)/World Health Organization (WHO) (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 30 - 70 years 2. Currently not under treatment for hypertension 3. Systolic blood pressure between 140 and 179 mmHg measured twice with a 5 to 10 minute interval 4. Informed consent given

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Trauma (injury) as presenting complaint 3. Renal diseases: nephropathy, renal artery stenosis 4. Endocrinological (hormonal) disorders: phaechromocytoma, Cushing syndrome, Conn syndrome, acromegaly 5. Coarctation of the aorta 6. Use of steroids and/or non-steroidal anti-inflammatories (NSAIs) 7. All acute conditions presenting with bleeding, pain, diarrhoea, vomiting, breathing disorders and circulatory disorders 8. Inability to comply with the follow-up requirements 9. Inability to provide informed consent

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Sri Lanka

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026